• Home
  • Explore Resources
    • Clinical
    • Scientific
    • Regulatory
    • Regulatory Links
  • Spotlight Topics
    • Potency Matters
    • Key Characteristics
  • About Us
  • Home
  • Explore Resources
    • Clinical
    • Scientific
    • Regulatory
    • Regulatory Links
  • Spotlight Topics
    • Potency Matters
    • Key Characteristics
  • About Us
  • Home
  • Explore Resources
    • Clinical
    • Scientific
    • Regulatory
    • Regulatory Links
  • Spotlight Topics
    • Potency Matters
    • Key Characteristics
  • About Us
The Human Relevant Potency Threshold: Reducing Uncertainty by Human Calibration of Cumulative Risk Assessments

The Human Relevant Potency Threshold: Reducing Uncertainty by Human Calibration of Cumulative Risk Assessments

by Michael Boyd | Jul 25, 2023 | Publications

The 2008 National Research Council report “Phthalates and Cumulative Risk Assessment: Tasks Ahead,” rejected the underlying premises of TEQ-like approaches – e.g., chemicals are true congeners; are metabolized and detoxified similarly; produce the same biological...
The Screening of Everyday Life Chemicals in Validated Assays Targeting the Pituitary-Gonadal Axis

The Screening of Everyday Life Chemicals in Validated Assays Targeting the Pituitary-Gonadal Axis

by Michael Boyd | Jul 25, 2023 | Publications

One molecule, caffeine, was further tested in rat pubertal assays at the tumorigenic doselevel and at dose-levels relevant for human consumption. In females pubertal parameters (vaginal opening, estrus cycle), ovarian weight and Fsh and prolactin transcript levels...
Upholding science in health, safety and environmental risk assessments and regulations

Upholding science in health, safety and environmental risk assessments and regulations

by Michael Boyd | Jul 25, 2023 | Publications

The appeal also notes that most national and international statutes delineating the discretion of regulators are ambiguous about what rules of evidence ought to apply. Those statutes should be revised to ensure that the evidence for regulatory action is grounded on...
What are They Saying About the Alleged Health Care and Lost Earnings Cost Estimates

What are They Saying About the Alleged Health Care and Lost Earnings Cost Estimates

by Michael Boyd | Jul 25, 2023 | Issue Analysis

Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances

Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances

by Susan Borgert | Jul 25, 2023 | Publications

Endocrine-disrupting substances (EDS) may have certain biological effects including delayed effects, multigenerational effects, and may display nonmonotonic dose–response (NMDR) relationships that require careful consideration when determining environmental hazards....
« Older Entries
Next Entries »

Recent Posts

  • Webinar 2: THE KEY CHARACTERISTICS APPROACH – A Mechanistic Misfit?
  • Webinar 1: The Key Characteristics Approach – Fit For Purpose
  • Endocrine Policy Forum website created

Recent Comments

    Archives

    • March 2026
    • October 2017

    Categories

    • Issue Analysis
    • Pamphlets
    • Presentations
    • Publications
    • Spotlight Topic
    • Uncategorized
    • Videos

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Contact Us

    The EPF welcomes your input and questions.